Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disorders of prolactin secretion.

M E Molitch1

  • 1Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA. molitch@northwestern.edu

Endocrinology and Metabolism Clinics of North America
|September 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship Between Hyperglycemia and Heart Transplant Rejection.

Transplantation proceedings·2015
Same author

Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.

The Journal of clinical endocrinology and metabolism·2013
Same author

Growth hormone treatment in adults with growth hormone deficiency: the transition.

Journal of endocrinological investigation·2011
Same author

Endocrine problems in the chronically critically ill patient.

Clinics in chest medicine·2001
Same author

Antipsychotic drug-induced hyperprolactinemia: clinical implications.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Growth hormone therapy for hypopituitary adults: time for re-appraisal.

Trends in endocrinology and metabolism: TEM·2000

Prolactinomas, tumors causing high prolactin levels, often lead to reproductive issues. Medical treatments like bromocriptine or cabergoline are typically effective, with surgery as a secondary option.

Area of Science:

  • Endocrinology
  • Oncology
  • Reproductive Medicine

Background:

  • Prolactinomas are common pituitary tumors.
  • They are a frequent cause of reproductive and sexual dysfunction.
  • Hyperprolactinemia requires exclusion of other causes before diagnosis.

Purpose of the Study:

  • To outline the diagnostic and therapeutic approaches for prolactinomas.
  • To discuss the efficacy and tolerability of different treatment modalities.

Main Methods:

  • Diagnosis involves excluding other causes of hyperprolactinemia.
  • Imaging studies like MRI or CT are used to determine tumor size and extent.
  • Treatment strategies include medical therapy and surgery.

Main Results:

Related Experiment Videos

  • Medical therapy is the primary treatment for prolactinomas.
  • Bromocriptine is preferred for infertility indications due to its safety.
  • Cabergoline shows higher efficacy and better tolerability for other indications.
  • Transsphenoidal surgery is an option for specific cases, particularly microadenomas unresponsive to medication.

Conclusions:

  • Prolactinomas can be effectively managed with medical therapy.
  • Medication choice depends on the specific indication and patient tolerance.
  • Surgery is reserved for refractory cases or specific tumor types.